Eisai initiates rolling submission for Leqembi autoinjector BLA to FDA

BioArctic AB's partner Eisai has initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb ... Read More